A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)

Clinical trial NCT05067283 · RECRUITING

Trial details

NCT number: NCT05067283
Sponsor: Merck Sharp & Dohme LLC
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2021-12-17
Primary completion: 2030-02-25
Enrollment: 830

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.